Aberrant Wnt signaling pathway in medial temporal lobe structures of Alzheimer’s disease

Journal of Neural Transmission

Volumn 122, Issue 9, 2015, Pages 1303-1318

  Riise, Jesper ^a,b,c   Plath, Niels ^a   Pakkenberg, Bente ^b   Parachikova, Anna ^a  

^a H LUNDBECK A S   (Denmark)

^b BISPEBJERG HOSPITAL   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Alzheimer s disease; Dementia; Entorhinal cortex; Hippocampus; Human; Wnt pathway

Indexed keywords

BETA CATENIN; EPITOPE; PROTEIN; TAU PROTEIN; TRANSCRIPTION FACTOR 7 LIKE 1; WNT7B PROTEIN; MAPT PROTEIN, HUMAN; MESSENGER RNA;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN REGION; COGNITIVE DEFECT; CONTROLLED STUDY; ENTORHINAL CORTEX; FEMALE; GENE EXPRESSION; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; MALE; MEDIAL TEMPORAL LOBE; NEUROFIBRILLARY TANGLE; OVERLAPPING GENE; PHOSPHORYLATION; PRIORITY JOURNAL; VERY ELDERLY; WNT SIGNALING PATHWAY; IMMUNOBLOTTING; METABOLISM; MIDDLE AGED; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ENTORHINAL CORTEX; FEMALE; HIPPOCAMPUS; HUMANS; IMMUNOBLOTTING; MALE; MIDDLE AGED; PHOSPHORYLATION; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; TAU PROTEINS; WNT SIGNALING PATHWAY;

EID: 84939567822     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-015-1375-7     Document Type: Article

References (69)

1. Ahmad-Annuar A et al (2006) Signaling across the synapse: a role for Wnt and Dishevelled in presynaptic assembly and neurotransmitter release. J Cell Biol 174:127–139. doi:10.1083/jcb.200511054
2. Alarcon MA et al (2013) A novel functional low-density lipoprotein receptor-related protein 6 gene alternative splice variant is associated with Alzheimer’s disease. Neurobiol Aging 34(1709):e1709–e1718. doi:10.1016/j.neurobiolaging.2012.11.004
3. Allen G et al (2007) Reduced hippocampal functional connectivity in Alzheimer disease. Arch Neurol 64:1482–1487. doi:10.1001/archneur.64.10.1482
4. Andersen CL, Jensen JL, Orntoft TF (2004) Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets. Cancer Res 64:5245–5250. doi:10.1158/0008-5472.CAN-04-0496
5. Baum L, Hansen L, Masliah E, Saitoh T (1996) Glycogen synthase kinase 3 alteration in Alzheimer disease is related to neurofibrillary tangle formation Molecular and chemical neuropathology/sponsored by the International Society for Neurochemistry and the World Federation of Neurology and research groups on neurochemistry and cerebrospinal fluid 29:253–261 doi:10.1007/BF02815006
6. Blalock EM, Geddes JW, Chen KC, Porter NM, Markesbery WR, Landfield PW (2004) Incipient Alzheimer’s disease: microarray correlation analyses reveal major transcriptional and tumor suppressor responses. Proc Natl Acad Sci USA 101:2173–2178. doi:10.1073/pnas.0308512100
7. Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82:239–259
8. Braak H, Braak E, Bohl J (1993) Staging of Alzheimer-related cortical destruction. Euro Neurol 33:403–408
9. Buee L, Bussiere T, Buee-Scherrer V, Delacourte A, Hof PR (2000) Tau protein isoforms, phosphorylation and role in neurodegenerative disorders Brain research. Brain Res Rev 33:95–130
10. Caricasole A et al (2004) Induction of Dickkopf-1, a negative modulator of the Wnt pathway, is associated with neuronal degeneration in Alzheimer’s brain. J Neurosci Off J Soc Neurosci 24:6021–6027. doi:10.1523/JNEUROSCI.1381-04.2004
11. Cerpa W, Farias GG, Godoy JA, Fuenzalida M, Bonansco C, Inestrosa NC (2010) Wnt-5a occludes Abeta oligomer-induced depression of glutamatergic transmission in hippocampal neurons. Molecular Neurodegener 5:3. doi:10.1186/1750-1326-5-3
12. Cerpa W, Gambrill A, Inestrosa NC, Barria A (2011) Regulation of NMDA-receptor synaptic transmission by Wnt signaling. J Neurosci Off J Soc Neurosci 31:9466–9471. doi:10.1523/JNEUROSCI.6311-10.2011
13. Chen J, Park CS, Tang SJ (2006) Activity-dependent synaptic Wnt release regulates hippocampal long term potentiation. J Biol Chem 281:11910–11916. doi:10.1074/jbc.M511920200
14. Ciani L, Salinas PC (2005) WNTs in the vertebrate nervous system: from patterning to neuronal connectivity. Nature Rev Neurosci 6:351–362. doi:10.1038/nrn1665
15. Davis EK, Zou Y, Ghosh A (2008) Wnts acting through canonical and noncanonical signaling pathways exert opposite effects on hippocampal synapse formation. Neural Development 3:32. doi:10.1186/1749-8104-3-32
16. De Ferrari GV, Inestrosa NC (2000) Wnt signaling function in Alzheimer’s disease. Brain Res Brain Res Rev 33:1–12
17. DeKosky ST, Scheff SW (1990) Synapse loss in frontal cortex biopsies in Alzheimer’s disease: correlation with cognitive severity. Ann Neurol 27:457–464. doi:10.1002/ana.410270502
18. Dickins EM, Salinas PC (2013) Wnts in action: from synapse formation to synaptic maintenance. Front Cell Neurosci 7:162. doi:10.3389/fncel.2013.00162
19. Ferrer I, Barrachina M, Puig B (2002) Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer’s disease. Pick’s disease, progressive supranuclear palsy and corticobasal degeneration. Acta Neuropathol 104:583–591. doi:10.1007/s00401-002-0587-8
20. Fortress AM, Schram SL, Tuscher JJ, Frick KM (2013) Canonical Wnt signaling is necessary for object recognition memory consolidation. J Neurosci Off J Soc Neurosci 33:12619–12626. doi:10.1523/JNEUROSCI.0659-13.2013
21. Ghanevati M, Miller CA (2005) Phospho-beta-catenin accumulation in Alzheimer’s disease and in aggresomes attributable to proteasome dysfunction. J Mol Neurosc MN 25:79–94. doi:10.1385/JMN:25:1:079
22. Glenner GG, Wong CW (1984) Alzheimer’s disease and Down’s syndrome: sharing of a unique cerebrovascular amyloid fibril protein. Biochem Biophys Res Commun 122:1131–1135
23. Goedert M, Spillantini MG, Jakes R, Rutherford D, Crowther RA (1989) Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer’s disease. Neuron 3:519–526
24. Gogolla N, Galimberti I, Deguchi Y, Caroni P (2009) Wnt signaling mediates experience-related regulation of synapse numbers and mossy fiber connectivities in the adult hippocampus. Neuron 62:510–525. doi:10.1016/j.neuron.2009.04.022
25. Gomez Ravetti M, Rosso OA, Berretta R, Moscato P (2010) Uncovering molecular biomarkers that correlate cognitive decline with the changes of hippocampus’ gene expression profiles in Alzheimer’s disease PloS one 5:e10153. doi:10.1371/journal.pone.0010153
26. Greicius MD, Srivastava G, Reiss AL, Menon V (2004) Default-mode network activity distinguishes Alzheimer’s disease from healthy aging: evidence from functional MRI. Proc Natl Acad Sci USA 101:4637–4642. doi:10.1073/pnas.0308627101
27. Hooper C, Killick R, Lovestone S (2008) The GSK3 hypothesis of Alzheimer’s disease. J Neurochem 104:1433–1439. doi:10.1111/j.1471-4159.2007.05194.x
28. Imahori K, Uchida T (1997) Physiology and pathology of tau protein kinases in relation to Alzheimer’s disease. J Biochem 121:179–188
29. Inestrosa NC, Varela-Nallar L (2014) Wnt signaling in the nervous system and in Alzheimer’s disease. J Molecul Cell Biol 6:64–74. doi:10.1093/jmcb/mjt051
30. Koppelkamm A, Vennemann B, Lutz-Bonengel S, Fracasso T, Vennemann M (2011) RNA integrity in post-mortem samples: influencing parameters and implications on RT-qPCR assays. Int J Legal Med 125:573–580. doi:10.1007/s00414-011-0578-1
31. Kwok JB et al (2008) Glycogen synthase kinase-3beta and tau genes interact in Alzheimer’s disease. Ann Neurol 64:446–454. doi:10.1002/ana.21476
32. Leroy K, Yilmaz Z, Brion JP (2007) Increased level of active GSK-3beta in Alzheimer’s disease and accumulation in argyrophilic grains and in neurones at different stages of neurofibrillary degeneration. Neuropathol Appl Neurobiol 33:43–55. doi:10.1111/j.1365-2990.2006.00795.x
33. Lie DC, Colamarino SA, Song HJ, Désiré L, Mira H, Consiglio A, Lein E, Jessberger S, Lansford H, Deaire AR, Gage FH (2005) Wnt signalling regulates adult hippocampal neurogenesis. Nat Lett 437:1370–1375. doi:10.1038/nature04108
34. Lucas JJ, Hernandez F, Gomez-Ramos P, Moran MA, Hen R, Avila J (2001) Decreased nuclear beta-catenin, tau hyperphosphorylation and neurodegeneration in GSK-3beta conditional transgenic mice. EMBO J 20:27–39. doi:10.1093/emboj/20.1.27
35. Maguschak KA, Ressler KJ (2008) Beta-catenin is required for memory consolidation. Nat Neurosci 11:1319–1326. doi:10.1038/nn.2198
36. Masliah E, Mallory M, Hansen L, DeTeresa R, Alford M, Terry R (1994) Synaptic and neuritic alterations during the progression of Alzheimer’s disease. Neurosci Lett 174:67–72
37. Mateo I, Infante J, Llorca J, Rodriguez E, Berciano J, Combarros O (2006) Association between glycogen synthase kinase-3beta genetic polymorphism and late-onset Alzheimer’s disease. Dement Geriatr Cogn Disord 21:228–232. doi:10.1159/000091044
38. Mirra SS et al (1991) The Consortium to Establish a Registry for Alzheimer’s Disease (CERAD). Part II. standardization of the neuropathologic assessment of Alzheimer’s disease. Neurology 41:479–486
39. Murase S, Mosser E, Schuman EM (2002) Depolarization drives beta-Catenin into neuronal spines promoting changes in synaptic structure and function. Neuron 35:91–105
40. Newmark RE, Schon K, Ross RS, Stern CE (2013) Contributions of the hippocampal subfields and entorhinal cortex to disambiguation during working memory. Hippocampus 23:467–475. doi:10.1002/hipo.22106
41. Okawa Y, Ishiguro K, Fujita SC (2003) Stress-induced hyperphosphorylation of tau in the mouse brain. FEBS Lett 535:183–189
42. Oliva CA, Vargas JY, Inestrosa NC (2013) Wnt signaling: role in LTP, neural networks and memory. Ageing Res Rev 12:786–800. doi:10.1016/j.arr.2013.03.006
43. Pei JJ, Tanaka T, Tung YC, Braak E, Iqbal K, Grundke-Iqbal I (1997) Distribution, levels, and activity of glycogen synthase kinase-3 in the Alzheimer disease brain. J Neuropathol Exp Neurol 56:70–78
44. Penna I, Vella S, Gigoni A, Russo C, Cancedda R, Pagano A (2011) Selection of candidate housekeeping genes for normalization in human postmortem brain samples. Int J Mol Sci 12:5461–5470. doi:10.3390/ijms12095461
45. Pfaffl MW, Tichopad A, Prgomet C, Neuvians TP (2004) Determination of stable housekeeping genes, differentially regulated target genes and sample integrity: best keeper–excel-based tool using pair-wise correlations. Biotechnol Lett 26:509–515
46. Reynolds CH, Betts JC, Blackstock WP, Nebreda AR, Anderton BH (2000) Phosphorylation sites on tau identified by nanoelectrospray mass spectrometry: differences in vitro between the mitogen-activated protein kinases ERK2, c-Jun N-terminal kinase and P38, and glycogen synthase kinase-3beta. J Neurochem 74:1587–1595
47. Rizzu P et al (2000) Mutation-dependent aggregation of tau protein and its selective depletion from the soluble fraction in brain of P301L FTDP-17 patients. Hum Mol Genet 9:3075–3082
48. Sahara N et al (2013) Characteristics of TBS-extractable hyperphosphorylated tau species: aggregation intermediates in rTg4510 mouse brain. J Alzheimer’s Dis JAD 33:249–263. doi:10.3233/JAD-2012-121093
49. Salcedo-Tello P, Ortiz-Matamoros A, Arias C (2011) GSK3 Function in the Brain during Development. Neuronal Plasticity Neurodegener Int J Alzheimer’s Dis 2011:189728. doi:10.4061/2011/189728
50. Schaffer BA et al (2008) Association of GSK3B with Alzheimer disease and frontotemporal dementia. Arch Neurol 65:1368–1374. doi:10.1001/archneur.65.10.1368
51. Scheff SW, Price DA, Schmitt FA, Mufson EJ (2006) Hippocampal synaptic loss in early Alzheimer’s disease and mild cognitive impairment. Neurobiol Aging 27:1372–1384. doi:10.1016/j.neurobiolaging.2005.09.012
52. Seib DR et al (2013) Loss of Dickkopf-1 restores neurogenesis in old age and counteracts cognitive decline. Cell Stem Cell 12:204–214. doi:10.1016/j.stem.2012.11.010
53. Selkoe DJ (2011) Alzheimer’s disease. Cold Spring Harb Perspect Biol. doi:10.1101/cshperspect.a004457
54. Shruster A, Eldar-Finkelman H, Melamed E, Offen D (2011) Wnt signaling pathway overcomes the disruption of neuronal differentiation of neural progenitor cells induced by oligomeric amyloid beta-peptide. J Neurochem 116:522–529. doi:10.1111/j.1471-4159.2010.07131.x
55. Silver N, Best S, Jiang J, Thein SL (2006) Selection of housekeeping genes for gene expression studies in human reticulocytes using real-time PCR. BMC Mol Biol 7:33. doi:10.1186/1471-2199-7-33
56. Sperber BR, Leight S, Goedert M, Lee VM (1995) Glycogen synthase kinase-3 beta phosphorylates tau protein at multiple sites in intact cells. Neurosci Lett 197:149–153
57. Squire LR, Zola-Morgan S (1991) The medial temporal lobe memory system. Science 253:1380–1386
58. Swatton JE, Sellers LA, Faull RL, Holland A, Iritani S, Bahn S (2004) Increased MAP kinase activity in Alzheimer’s and Down syndrome but not in schizophrenia human brain. Euro J Neurosci 19:2711–2719. doi:10.1111/j.0953-816X.2004.03365.x
59. Tabatadze N, Tomas C, McGonigal R, Lin B, Schook A, Routtenberg A (2012) Wnt transmembrane signaling and long-term spatial memory. Hippocampus 22:1228–1241. doi:10.1002/hipo.20991
60. Taniguchi S et al (2001) Calpain-mediated degradation of p35 to p25 in postmortem human and rat brains. FEBS Lett 489:46–50
61. van Eersel J et al (2009) Phosphorylation of soluble tau differs in Pick’s disease and Alzheimer’s disease brains. J Neural Trans 116:1243–1251. doi:10.1007/s00702-009-0293-y
62. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, Speleman F (2002) Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes Genome biology 3:RESEARCH0034
63. Varela-Nallar L, Alfaro IE, Serrano FG, Parodi J, Inestrosa NC (2010) Wingless-type family member 5A (Wnt-5a) stimulates synaptic differentiation and function of glutamatergic synapses. Proc Natl Acad Sci USA 107:21164–21169. doi:10.1073/pnas.1010011107
64. Varela-Nallar L, Parodi J, Farias GG, Inestrosa NC (2012) Wnt-5a is a synaptogenic factor with neuroprotective properties against Abeta toxicity. Neuro-Degener Dis 10:23–26. doi:10.1159/000333360
65. Weis S, Llenos IC, Dulay JR, Elashoff M, Martinez-Murillo F, Miller CL (2007) Quality control for microarray analysis of human brain samples: the impact of postmortem factors. RNA characteristics, and histopathology. J Neurosci Methods 165:198–209. doi:10.1016/j.jneumeth.2007.06.001
66. Wiedau-Pazos M, Wong E, Solomon E, Alarcon M, Geschwind DH (2009) Wnt-pathway activation during the early stage of neurodegeneration in FTDP-17 mice. Neurobiol Aging 30:14–21. doi:10.1016/j.neurobiolaging.2007.05.015
67. Yuan Z, Agarwal-Mawal A, Paudel HK (2004) 14-3-3 binds to and mediates phosphorylation of microtubule-associated tau protein by Ser9-phosphorylated glycogen synthase kinase 3beta in the brain. J Biol Chem 279:26105–26114. doi:10.1074/jbc.M308298200
68. Zhang Z et al (1998) Destabilization of beta-catenin by mutations in presenilin-1 potentiates neuronal apoptosis. Nature 395:698–702. doi:10.1038/27208
69. Zhukareva V et al (2003) Selective reduction of soluble tau proteins in sporadic and familial frontotemporal dementias: an international follow-up study. Acta Neuropathol 105:469–476. doi:10.1007/s00401-002-0668-8